Glucagon‐like peptide‐1 (GLP‐1) receptor agonists and cardiovascular events in patients with type 2 diabetes mellitus: a meta‐analysis of double‐blind, randomized, placebo‐controlled clinical trials. The gene discussed is GLP1R; the disease is type 2 diabetes mellitus.